home / stock / bicx / bicx news


BICX News and Press, BioCorRx Inc. From 04/01/21

Stock Information

Company Name: BioCorRx Inc.
Stock Symbol: BICX
Market: OTC
Website: biocorrx.com

Menu

BICX BICX Quote BICX Short BICX News BICX Articles BICX Message Board
Get BICX Alerts

News, Short Squeeze, Breakout and More Instantly...

BICX - BioCorRx Provides 2020 Year-End Business Update

ANAHEIM, CA, April 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use disorders, today provided a year-end business update for 2020 and repor...

BICX - BioCorRx Completes $2.25 Million Private Placement

ANAHEIM, CA, March 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use disorders, today announced that the Company completed a private placeme...

BICX - BioCorRx Appoints Finance Veteran Joseph J. Galligan to the Board of Directors

Anaheim, CA - ( NewMediaWire ) - February 24, 2021 - BioCorRx Inc. (OTCQB: BICX) (the “Company”),  a developer and provider of advanced solutions in the treatment of substance use disorders, today announced that Joseph J. Galligan was appointed to the Company’s Bo...

BICX - BioCorRx wins revised notice of award to extend NIDA grant for naltrexone implant development

BioCorRx (BICX) has received a revised notice of award ((NoA)) to extend the current UG3 phase of the grant awarded by the National Institute on Drug Abuse ((NIDA)), part of the National Institutes of Health ((NIH)).The grant was awarded to support the advancement of a sustaine...

BICX - BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders

ANAHEIM, CA, Jan. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use disorders, today announced that it has received a revised notice of award (NoA) ...

BICX - BioCorRx Provides Business Update for the Third Quarter of 2020; BioCorRx Subsidiary, BioCorRx Pharmaceuticals Inc. Progressing with Pivotal Nonclinical BICX102 Study

Announces Promotion of Lourdes Felix to CEO; Brady Granier to Serve as President Anaheim, CA - ( NewMediaWire ) - November 16, 2020 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of advanced solutions in the treatment of substance use disorde...

BICX - BioCorRx Partners with Truusight Health to Integrate Recovery Program Into Self-Funded Health Plans

Anaheim, CA - ( NewMediaWire ) - October 13, 2020 - BioCorRx Inc. (OTCQB: BICX) (“BioCorRx®”) (“Company”), a developer and provider of advanced solutions in the treatment of substance use disorders (SUD), today announced their partnership with  Truusi...

BICX - BioCorRx Provides Business Update for the Second Quarter of 2020

ANAHEIM, CA, Aug. 14, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of advanced solutions in the treatment of substance use disorders, today provided a business update for the second quarter ended June 30, ...

BICX - BioCorRx Provides Update on Current Business Operations and on GLP Studies of BICX102; Uninterrupted by COVID-19 Pandemic

ANAHEIM, CA, May 22, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of advanced solutions in the treatment of substance use disorders, today provided a business update and reported on recent corporate develo...

BICX - BioCorRx Offers Free Access to the UnCraveRx(TM) Mobile Platform for Weight Loss Management During COVID-19 Pandemic

ANAHEIM, CA, April 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of advanced solutions in the treatment of substance use disorders, today announced that it is offering free access to the UnCraveRxȒ...

Previous 10 Next 10